在帕金森病中,subthalamic核动力学追踪微损伤效应
Chunkai Peng1, Zhuyong Wang1, Yujia Sun1
1Neurosurgery Center, Department of Functional Neurosurgery, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The Neurosurgery Institute of Guangdong Province, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Frontiers in cell and developmental biology
|March 4, 2024
概括
帕金森病 (PD) 中的微损伤效应涉及手术后暂时缓解症状. 这项研究揭示了这一时期大脑信号模式 (LFP) 的变化,为PD机制和治疗优化提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 运动症状在术后暂时改善 (微伤效应).
- 在PD中微损伤效应 (MLE) 期间的电生理学变化尚不清楚.
- 脑下细胞核 (STN) 局部场潜力 (LFP) 是了解PD的关键.
研究的目的:
- 在PD患者的超急性 (≤2天) 和植入后1个月期间调查STN-LFP信号特征.
- 在MLE期间区分神经元功率光谱的周期性和非周期性组成部分.
- 评估药物 (莱沃多巴) 对这些电生理学参数的影响.
主要方法:
- 对15名经过电极植入的PD患者进行观察性研究.
- 使用无线传感技术同时进行双边STN-LFP记录.
- 在超急性和植入后1个月间隔的药物和药物停用状态下分析LFP信号.
- 神经元功率频谱的参数化,以分离周期性和非周期性信号组件.
主要成果:
- 在非药物状态下,贝塔功率在植入后1个月显著增加,与超急性期相比.
- 勒沃多巴的使用有效地降低了这种升高的β功率.
- 无周期信号组件 (指数和偏移) 在植入后1个月下降.
- 列沃多巴调节了非周期性参数,使其恢复到超急性水平.
结论:
- 周期性 (β功率) 和非周期性LFP组件都反映了PD中MLE期间明显的电生理学变化.
- 了解这些周期性和非周期性动态对于阐明MLE机制至关重要.
- 准确评估这些信号组件可以帮助优化PD的自适应性深度大脑刺激协议.
更多相关视频
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544


